Breaking News - The Fly

Open Search

IMMP

Immutep

$

()

Immutep announces preliminary topline results from TACTI-003 Cohort B

IMMP

4/24/2024 - 08:14am

Immutep engers agreement with Centre for Human Drug Research

IMMP

4/18/2024 - 08:15am

Immutep receives feedback from the Spanish AEMPS for TACTI-004 trial

IMMP

4/17/2024 - 08:06am

Immutep announces first clinical data from 90mg dosing of efti

IMMP

3/5/2024 - 08:08am

Immutep reports Q2 cash receipts $38K vs. $132K last quarter

IMMP

1/30/2024 - 08:16am

Immutep announces first patient enrolled, dosed in INSIGHT-005 trial

IMMP

1/4/2024 - 08:30am

Immutep receives constructive feedback on TACTI-004 trial

IMMP

12/21/2023 - 08:08am

Immutep receives EUR 1.595M R&D tax incentive from French government

IMMP

12/7/2023 - 08:11am

Immutep announces site expansion for INSIGHT-003 Phase I trial

IMMP

11/22/2023 - 08:05am

Immutep completes enrollment in TACTI-003 Phase IIb trial

IMMP

11/9/2023 - 08:22am

Immutep announces completion of lead-in, opening of Phase II study of AIPAC-003

IMMP

11/6/2023 - 08:29am

Immutep announces new biomarker data from TACTI-002 Phase II

IMMP

11/3/2023 - 12:20pm

Immutep reports Q1 cash receipts $132K vs. $16K last quarter

IMMP

10/31/2023 - 08:18am

Immutep receives A$1,134,882 R&D tax incentive

IMMP

10/25/2023 - 08:07am

Immutep reports clinical data from INSIGHT-003 trial

IMMP

10/24/2023 - 08:22am